Up Fintech Stock (NASDAQ: TIGR) Outperforming Markets Leading into Earnings

UP Fintech's stock (NASDAQ: TIGR) has been handily outperforming broader markets as it heads into earnings this morning.  TIGR has set a strong pace since the start of this year, adding 29.2% to the price, and bringing the 12 month cumulative gain to an impressive 103.62%, for a double up. This comes as the broader Nasdaq 100 has delivered gains of 1.85%, and 15.2% over the same period. A handy outperformance indeed, but can the momentum be maintained after earnings?

The company, a fintech powerhouse behind the Tiger Brokers brand, is expected to post $111.6million in revenue on the quarter, for a 41.36% year-over-year improvement.

The anticipation could be justified, given UP Fintech’s recent history of outperformance. In Q4 2024, the company reported $124 million in revenue and $0.17 earnings per share, both handily beating analyst expectations.

Much of TIGR’s success can be traced to its aggressive international expansion strategy. The company has established a notable presence across Singapore, Hong Kong, New Zealand, Australia, and the United States. Singapore remains its largest market, but recent double-digit asset growth in Hong Kong and the acquisition of FreeNow to bolster its European trading platform signal a clear commitment to global diversification.

As of February 2025, UP Fintech reported record global client assets of $41.7 billion, underlining the effectiveness of its cross-border investment platform. Management has also emphasized ongoing market entries and partnerships as future value drivers, with market rumors swirling about a potential tie-up with a major technology player—an event that could further enhance its competitive advantages.

UP Fintech’s balance sheet remains solid, with $6.39 billion in assets against $5.73 billion in liabilities. Its price-to-earnings ratio of 23.7, while high, reflects the market’s expectation of continued robust growth. However, this valuation premium also introduces risk, especially if growth slows or if market sentiment turns.

Looking to analysts, the consensus price target of $9.86 reflects healthy perceived upside from here, although not all sentiment is uniformly bullish. On April 22, BofA’s Emma Xu lowered the price target to $7.76 from $8.66 and trimmed FY25-27 EPS estimates by 8%-10%, citing concerns over lower client assets and trading velocity. Yet, Xu maintained a Buy rating, arguing that recent price corrections at the time had already factored in many of these risks. The stock has already gained 18% from that point.

As the company prepares to unveil its Q1 2025 results, markets will be looking for commentary surrounding the future expectations, weighing what is a compelling growth narrative against the realities of market volatility and premium valuations.